Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|August 2, 2014
Are evoked potentials in patients with adult-onset pompe disease indicative of clinically relevant central nervous system involvement?Andreas Wirsching, Wolfgang Müller-Felber, Benedikt Schoser
Zeitschrift Fur Rheumatologie|May 23, 2024
[CAR T-cell therapy in rheumatology-What we know so far?]Melanie Hagen, Andreas Wirsching, Daniela Bohr, et al.
The Journal of Rheumatology|September 15, 2025
Effects of CD19 CAR T Cell Therapy on Quality of Life and Direct Healthcare Costs in Systemic Lupus Erythematosus: A Preliminary AnalysisJule Taubmann, Melanie Hagen, Fabian Müller, et al.
Zeitschrift Fur Rheumatologie|September 4, 2025
[Long-term follow up of efficiency and safety of CD19-CAR T-cell treatment of systemic lupus erythematosus]Jule Taubmann, Sebastian Böltz, Melanie Hagen, et al.
RMD Open|June 29, 2026
Real-world longitudinal assessment of anifrolumab in patients with systemic lupus erythematosus: clinical outcomes, safety and modulation of cytokines and neutrophil activityAlp Temiz, Rita Noversa de Sousa, Janina Schoen, et al.
Rheumatology International|June 22, 2026
Impact of Yoga on Spinal Mobility and Psychological Outcomes in Patients with Axial Spondyloarthritis: A Prospective Non-randomized Controlled StudyVanessa Bundle, Claudia Bouzas, Alp Temiz, et al.
Annals of the Rheumatic Diseases|July 23, 2025
Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosusPanagiotis Garantziotis, Lorenzo Beretta, Julius Lindblom, et al.
Nature Medicine|April 17, 2025
BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cellsFabian Müller, Andreas Wirsching, Melanie Hagen, et al.
Arthritis Research & Therapy|December 3, 2024
Impact of the digital health application ViViRA on spinal mobility, physical function, quality of life and pain perception in spondyloarthritides patients: a randomized controlled trialPaloma Palm von Alten Blaskowitz, Anna-Maria Liphardt, Claudia Bouzas, et al.
Nature Medicine|April 26, 2024
Bispecific T cell engager therapy for refractory rheumatoid arthritisLaura Bucci, Melanie Hagen, Tobias Rothe, et al.
Pageof 2